These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24123921)

  • 1. Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees.
    Bousman CA; Potiriadis M; Everall IP; Gunn JM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):62-7. PubMed ID: 24123921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
    Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL
    J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives.
    Cannon DM; Walshe M; Dempster E; Collier DA; Marshall N; Bramon E; Murray RM; McDonald C
    Transl Psychiatry; 2012 Oct; 2(10):e167. PubMed ID: 23032943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis.
    Bousman CA; Yung AR; Pantelis C; Ellis JA; Chavez RA; Nelson B; Lin A; Wood SJ; Amminger GP; Velakoulis D; McGorry PD; Everall IP; Foley DL
    Transl Psychiatry; 2013 Apr; 3(4):e251. PubMed ID: 23632455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional neuregulin-1 gene variant and stressful life events: Effect on drug use in a longitudinal population-representative cohort study.
    Vaht M; Laas K; Kiive E; Parik J; Veidebaum T; Harro J
    J Psychopharmacol; 2017 Jan; 31(1):54-61. PubMed ID: 27353026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin-1 immunoreactivity in peripheral plasma is associated with rs6982890 polymorphism-mediated psychotic symptoms in schizophrenia.
    Wang X; Zhou J; Ding S; Zhang J; Liu Y; Liu Y; Zhao J; Shi H; Liu Q; Song M; Lv L; Li W; Yang Y
    Brain Res Bull; 2024 Oct; 217():111075. PubMed ID: 39255944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia-risk variant rs6994992 in the neuregulin-1 gene on brain developmental trajectories in typically developing children.
    Douet V; Chang L; Pritchett A; Lee K; Keating B; Bartsch H; Jernigan TL; Dale A; Akshoomoff N; Murray S; Bloss C; Kennedy DN; Amaral D; Gruen J; Kaufmann WE; Casey BJ; Sowell E; Ernst T
    Transl Psychiatry; 2014 May; 4(5):e392. PubMed ID: 24865593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.
    Wilkosz PA; Kodavali C; Weamer EA; Miyahara S; Lopez OL; Nimgaonkar VL; DeKosky ST; Sweet RA
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1054-62. PubMed ID: 17525976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees.
    Bousman CA; Potiriadis M; Everall IP; Gunn JM
    J Affect Disord; 2014 Aug; 165():64-8. PubMed ID: 24882179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis.
    Jagannath V; Gerstenberg M; Walitza S; Franscini M; Heekeren K; Rössler W; Theodoridou A; Grünblatt E
    Psychiatry Res; 2018 Aug; 266():143-146. PubMed ID: 29864613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that genes for depression impact on the pathway from trauma to psychotic-like symptoms by occasioning emotional dysregulation.
    Kramer IM; Simons CJ; Myin-Germeys I; Jacobs N; Derom C; Thiery E; van Os J; Wichers M
    Psychol Med; 2012 Feb; 42(2):283-94. PubMed ID: 21835094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation at NRG1 genotype related to modulation of small-world properties of the functional cortical network.
    Lubeiro A; Gomez-Pilar J; Martín O; Palomino A; Fernández M; González-Pinto A; Poza J; Hornero R; Molina V
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):25-32. PubMed ID: 26650688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.
    Zai CC; Tiwari AK; Chowdhury NI; Yilmaz Z; de Luca V; Müller DJ; Potkin SG; Lieberman JA; Meltzer HY; Voineskos AN; Remington G; Kennedy JL
    World J Biol Psychiatry; 2019 Jan; 20(1):91-95. PubMed ID: 28394697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees.
    Bousman CA; Potiriadis M; Everall IP; Gunn JM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):68-76. PubMed ID: 24123968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the 3' region of the neuregulin 1 gene with bipolar I disorder in the Chinese Han population.
    Cao L; Deng W; Guan L; Yang Z; Lin Y; Ma X; Li X; Liu Y; Ye B; Lao G; Chen Y; Liang H; Wu Y; Ou Y; Huang W; Liu W; Wang Q; Wang Y; Zhao L; Li T; Hu X
    J Affect Disord; 2014 Jun; 162():81-8. PubMed ID: 24767010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort study.
    Bousman CA; Gunn JM; Potiriadis M; Everall IP
    World J Biol Psychiatry; 2017 Feb; 18(1):75-81. PubMed ID: 26878222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression.
    Andre K; Kampman O; Viikki M; Setälä-Soikkeli E; Illi A; Mononen N; Lehtimäki T; Leinonen E
    Acta Neuropsychiatr; 2018 Jun; 30(3):168-174. PubMed ID: 29310728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived discrimination is associated with severity of positive and depression/anxiety symptoms in immigrants with psychosis: a cross-sectional study.
    Berg AO; Melle I; Rossberg JI; Romm KL; Larsson S; Lagerberg TV; Andreassen OA; Hauff E
    BMC Psychiatry; 2011 May; 11():77. PubMed ID: 21548949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mediating role of psychological flexibility in the relationship between psychotic symptom severity and depression in individuals diagnosed with schizophrenia.
    Yıldız E; Yıldırım Ö
    J Psychiatr Ment Health Nurs; 2024 Oct; 31(5):869-882. PubMed ID: 38469987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.